spacer
home > epc > spring 2009 > competing with big pharma
PUBLICATIONS
European Pharmaceutical Contractor

Competing with Big Pharma

Good ideas for new drugs can come from anywhere. There was a time – now it seems like ancient history – when virtually all ideas came from the R&D departments of large pharmaceutical companies. Today, they often come from research carried out by dedicated groups of scientists at universities and small and medium-sized biotech firms, or even ‘virtual’ research groups connected by the internet.

Regardless of how it’s achieved, coming up with a concept for a new drug is not a random event. It starts with deciding what questions to ask in order to identify potential targets for a disease, and later focuses on developing strategies to find effective candidates that selectively affect those targets. Through hard work and trial and error, thousands of labs across the UK are developing new candidates every day. Thankfully, with some regularity, one scientist will turn to his or her colleagues and say, “I think we’ve got something here.” Then what?


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Mark Crane joined Ricerca as Vice President, Business Development and Marketing in June 2007. Mark has overseen the development of the new Ricerca ‘IP to IND’ brand, as well as the development of the website and sales literature. Prior to joining Ricerca, Mark served as Vice President, Sales and Marketing, for both Bridge Global Pharmaceutical Services and Quest Pharmaceutical Services. Mark was also a Vice President, of Global Business Development, Preclinical/Discovery Services for MDS Pharmaceutical Services, and held various posts at MDS Panlabs, AVANTEC, Inc and the Perkin Elmer Corporation. He holds a BS degree in Health Education/Community Health from Western Connecticut State University at Danbury.

spacer
Mark Crane
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

EXTERNAL COMMUNICATION, 24 October 2019, Copenhagen, Denmark PRESS RELEASE – FLYPHARMA CONFERENCE EUROPE 2019

For its fifth annual Europe conference, FlyPharma chose Copenhagen as its host city to address the latest supply chain challenges and industry best practices, putting together a global audience of (bio)pharma and logistics professionals. The two-day conference (22-23 October 2019) aimed to discuss the collaboration and growth within Scandinavia, with a special focus on women in pharmaceutical logistics and an exploration of the industry’s digitalisation and innovation.
More info >>

White Papers

Tabletability, Compactability, and Compressibilty: What’s the Difference?

Natoli Engineering Company, Inc.

To patients and consumers, tablets are a simple and convenient dosage form. But the science behind compressing a block of particles or granules into a single tablet can be complicated. That’s where common compression studies can help. This article explains how to develop tabletability, compactibility, and compressibility profiles.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement